| __timestamp | BeiGene, Ltd. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6930000 | 6795238 |
| Thursday, January 1, 2015 | 7311000 | 7454247 |
| Friday, January 1, 2016 | 20097000 | 10345862 |
| Sunday, January 1, 2017 | 62602000 | 16984203 |
| Monday, January 1, 2018 | 195385000 | 16187290 |
| Tuesday, January 1, 2019 | 388249000 | 9299233.54 |
| Wednesday, January 1, 2020 | 600176000 | 19232000 |
| Friday, January 1, 2021 | 990123000 | 23611000 |
| Saturday, January 1, 2022 | 1277852000 | 26700000 |
| Sunday, January 1, 2023 | 1504501000 | 28215000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, understanding a company's operational efficiency is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of BeiGene, Ltd. and Summit Therapeutics Inc. from 2014 to 2023. Over this period, BeiGene's SG&A expenses skyrocketed by over 21,000%, reflecting its aggressive expansion and investment in global operations. In contrast, Summit Therapeutics maintained a more conservative growth, with expenses increasing by approximately 315%.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and BeiGene, Ltd.
BeiGene, Ltd. and Exelixis, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Viking Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xencor, Inc.
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Catalyst Pharmaceuticals, Inc.
Summit Therapeutics Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Vericel Corporation
Summit Therapeutics Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Evotec SE